 Drug combination for the treatment of pain is common clinical practice. Co-crystal of Tramadol-Celecoxib ( CTC) consists of two active pharmaceutical ingredients ( APIs) , namely the atypical opioid tramadol and the preferential cyclooxygenase-2 inhibitor celecoxib , at a 1:1 molecular ratio. In this study , a non-formulated ` raw ' form of CTC administered in suspension ( referred to as ctc